ArticleThe journal of physical chemistry letters2018
SABRE-Relay: A Versatile Route to Hyperpolarization.
Article in The journal of physical chemistry letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Nonresonant SABRE provides an additional versatile hyperpolarization approach in magnetic resonance.Science advances · 2026Article
- Article
- Scalable Hyperpolarized MRI Enabled by Ace-SABRE of [1-Angewandte Chemie (International ed. in English) · 2025Article
- Facile hyperpolarization chemistry for molecular imaging and metabolic tracking of [1-Journal of magnetic resonance open · 2023Article
- Detection of pyridine derivatives by SABRE hyperpolarization at zero field.Communications chemistry · 2023Article
- Relayed hyperpolarization for zero-field nuclear magnetic resonance.Science advances · 2022Article
- Article
- Instrumentation for Hydrogenative Parahydrogen-Based Hyperpolarization Techniques.Analytical chemistry · 2022Article
- Rapid SABRE Catalyst Scavenging Using Functionalized Silicas.Molecules (Basel, Switzerland) · 2022Article
- Density Functional Theory Study of Reaction Equilibria in Signal Amplification by Reversible Exchange.Chemphyschem : a European journal of chemical physics and physical chemistry · 2021Article
- Quantitative NMR-Based Biomedical Metabolomics: Current Status and Applications.Molecules (Basel, Switzerland) · 2020Review
- Rational ligand choice extends the SABRE substrate scope.Chemical communications (Cambridge, England) · 2020Article
- Automated pneumatic shuttle for magnetic field cycling and parahydrogen hyperpolarized multidimensional NMR.Journal of magnetic resonance (San Diego, Calif. : 1997) · 2020Article
- Hyperpolarization of Pyridyl Fentalogues by Signal Amplification By Reversible Exchange (SABRE).ChemistryOpen · 2019Article
- Understanding substrate substituent effects to improve catalytic efficiency in the SABRE hyperpolarisation process.Catalysis science & technology · 2019Article
- Hyperpolarising Pyruvate through Signal Amplification by Reversible Exchange (SABRE).Angewandte Chemie (International ed. in English) · 2019Article
- Pharmacokinetics of the SABRE agent 4,6-dEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2019Article
- Using coligands to gain mechanistic insight into iridium complexes hyperpolarized withChemical science · 2019Article
- Parahydrogen based NMR hyperpolarisation goes micro: an alveolus for small molecule chemosensing.Lab on a chip · 2019Article
- Unlocking a Diazirine Long-Lived Nuclear Singlet State via Photochemistry: NMR Detection and Lifetime of an Unstabilized Diazo-Compound.Journal of the American Chemical Society · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Signal Amplification by Reversible Exchange (SABRE) is used to switch on the latent singlet spin order of para-hydrogen (p-H
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.